Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of August 14, 2025 • 11:01 PM ET

Date/Time Source News Release
08/14/2025 08:55 AM EDT GlobeNewswire AIM ImmunoTech to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
08/06/2025 09:00 AM EDT GlobeNewswire AIM ImmunoTech's Oncology Drug Ampligen to Be Featured in Key Presentations and Abstract at the International 5th Annual Marie Sk?odowska-Curie Symposium on Cancer Research and Care (MSCI MSCS-2025)
08/04/2025 09:00 AM EDT GlobeNewswire AIM ImmunoTech Builds Positive Momentum and Reiterates Focus on Driving Ampligen® Clinical Development Toward Pancreatic Cancer Approval
07/31/2025 09:00 AM EDT GlobeNewswire AIM ImmunoTech Announces Closing of $8.0 Million Public Offering
07/29/2025 09:00 AM EDT GlobeNewswire AIM ImmunoTech Announces Pricing of $8.0 Million Public Offering
07/28/2025 09:00 AM EDT GlobeNewswire AIM ImmunoTech Reports Positive Mid-year Safety and Efficacy Data from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca's Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
07/02/2025 08:55 AM EDT GlobeNewswire AIM ImmunoTech Announces Recent Presentation on the Potential of Private-Public Partnerships for the Development of Oncology Therapies
06/20/2025 04:15 PM EDT GlobeNewswire AIM ImmunoTech Announces NYSE American Notice of Noncompliance With Minimum Stockholders' Equity Requirements
06/17/2025 08:55 AM EDT GlobeNewswire AIM ImmunoTech Resumes Trading on NYSE American
06/12/2025 08:30 AM EDT GlobeNewswire AIM ImmunoTech Granted U.S. Patent Covering Methods of Manufacturing Therapeutic dsRNA, Including Ampligen®
Page

Additional News

As of August 14, 2025 • 11:01 PM ET

Date/Time Source News Release
08/11/2025 06:55 PM EDT Zacks FibroGen (FGEN) Reports Q2 Loss, Lags Revenue Estimates
07/29/2025 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Tue, Jul 29, 2025 as of 4:00 pm ET
07/29/2025 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Tue, Jul 29, 2025 as of 10.00 am ET
07/29/2025 09:10 AM EDT SeekingAlpha AIM ImmunoTech announces pricing of $8 million public offering; shares down over 50%
07/29/2025 09:10 AM EDT SeekingAlpha AIM ImmunoTech slumps 50% after pricing $8M securities offering
07/28/2025 11:12 AM EDT 24/7 Market News Top Biotech Stocks to Watch Now: Momentum, Milestones & Market Breakouts
07/28/2025 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Mon, Jul 28, 2025 as of 10.00 am ET
05/15/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 15th, 2025
05/15/2025 05:31 AM EDT US Earnings Reports Expected earnings - AIM ImmunoTech Inc.
04/04/2025 04:55 PM EDT SeekingAlpha AIM ImmunoTech receives NYSE American notice of delisting and appeal
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.